ABBV
Abbvie·NYSE
--
--(--)
--
--(--)
ABBV fundamentals
Abbvie (ABBV) Revenue Breakdown: Q4 2025 Business & Regional Performance
Abbvie (ABBV) reported total revenue of 16.62B USD in Q4 2025, with its core business segment Immunology contributing 51.91%. Regionally, United States remained the largest market, accounting for 76.99% of total revenue. Explore Abbvie's revenue distribution across business segments and global markets to gain insights into its growth trends and market position.
Abbvie (ABBV) reported total revenue of 16.62B USD in Q4 2025, with its core business segment Immunology contributing 51.91%. Regionally, United States remained the largest market, accounting for 76.99% of total revenue. Explore Abbvie's revenue distribution across business segments and global markets to gain insights into its growth trends and market position.
By Business
No Data
By Region
No Data
You can ask Aime
What guidance did Abbvie's management provide for the next earnings period?What factors drove the changes in Abbvie's revenue and profit?What is the market's earnings forecast for Abbvie next quarter?What were the key takeaways from Abbvie’s earnings call?What does Abbvie do and what are its main business segments?Did Abbvie beat or miss consensus estimates last quarter?What is Abbvie's gross profit margin?What were the key takeaways from Abbvie's earnings call?
ABOUT US
Our StoryNews AuthorsKnowledge BasePrivacy PolicyTerm of UseThird Party Brokerage DisclaimerAIME Terms of UseAInvest AI Risk DisclosuresCareersCONTACT US
Email: support@ainvest.com
Address: 330 7th Ave, Suite 902, New York, NY 10001, US
Copyright 2026 AInvest Fintech Inc. All rights reserved.
